Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001-2007
Year of publication: |
2014
|
---|---|
Authors: | Conti, Rena |
Other Persons: | Berndt, Ernst R. (contributor) |
Publisher: |
[2014]: [S.l.] : SSRN |
Subject: | USA | United States | Patent | Arzneimittel | Pharmaceuticals | Preis | Price | Markteintritt | Market entry | Generika | Generic drugs | Krebskrankheit | Cancer |
Extent: | 1 Online-Ressource (48 p) |
---|---|
Series: | NBER Working Paper ; No. w20016 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments March 2014 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Specialty drug prices and utilization after loss of US patent exclusivity, 2001 - 2007
Conti, Rena M., (2014)
-
Specialty drug prices and utilization after loss of us patent exclusivity, 2001-2007
Conti, Rena M., (2018)
-
Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
Conti, Rena M., (2014)
- More ...
-
The Effect of Fda Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
Conti, Rena, (2013)
-
The Geography of Prescription Pharmaceuticals Supplied to the U.S : Levels, Trends and Implications
Kaygisiz, Neriman Beste, (2019)
-
The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration
Adajar, Paolo, (2021)
- More ...